In the Journals

Favorable prognosis of NPM1 mutations in AML lost in patients with poor cytogenetic risk

October 16, 2019
Patients with acute myeloid leukemia and adverse-risk cytogenetics had an unfavorable prognosis regardless of whether they harbored mutated or…

Trend Watch

Cameron Turtle Receives Fred Hutch’s Endowed Chair for Immunotherapy

Cell Therapy Next, October/November 2019
Cameron Turtle, MD, PhD, a pioneer in the field of chimeric antigen receptor T-cell therapy, has been honored as the inaugural recipient of the…

The Leukemia & Lymphoma Society awards $13.8 million for research into pediatric blood cancers

October 9, 2019
The Leukemia & Lymphoma Society awarded $13.8 million in new pediatric research grants designed to identify more effective and precise treatments…

FDA News

FDA awards $15 million to fund trials of treatments for rare diseases

October 8, 2019
The FDA awarded 12 grants worth more than $15 million to fund clinical trials of medical products intended to treat patients with rare diseases. The…

ASH presents bridge grants to 19 investigators

October 7, 2019
ASH awarded $150,000 each to 19 investigators through the society’s bridge grant program, designed to sustain promising hematologic research…


Researchers gain insight into link between Down syndrome, acute lymphoblastic leukemia

October 3, 2019
Children with Down syndrome face a 10 to 20 times higher risk for developing acute lymphoblastic leukemia than children without Down syndrome. …


Algorithm could help leverage data for pediatric oncology research

September 27, 2019
Investigators have developed an algorithm that appeared to accurately identify children with leukemia and lymphoma who would be appropriate for…

Two phase 3 studies show efficacy of blinatumomab over chemotherapy for pediatric leukemia

September 25, 2019
Blinatumomab significantly extended EFS compared with conventional consolidation chemotherapy among children with high-risk B-cell acute…


Seattle Cancer Care Alliance opens its doors to share its cellular therapy experience

September 18, 2019
The Seattle Cancer Care Alliance, the clinical care partner of the Fred Hutchinson Cancer Research Center, has been at the forefront of cellular…


AACR Cancer Progress Report: Past federal investments in NIH spurring breakthroughs in care

September 18, 2019
The American Association for Cancer Research today released its annual Cancer Progress Report, which reflects how prior investment in the NIH is…

Fred Hutchinson Cancer Research Center director to step down

September 17, 2019
D. Gary Gilliland, MD, PhD, president and director of Fred Hutchinson Cancer Research Center, announced today that he will step down next…

Trend Watch

Penn, Novartis end groundbreaking CAR-T relationship with new, more focused collaboration

September 16, 2019
The 7-year research and development alliance between Novartis and the University of Pennsylvania has concluded, with both organizations entering into…


CAR T-cell therapy has some patients crowdfunding to cover costs

September 13, 2019
Aletta Weiss plans to undergo chimeric antigen receptor T-cell treatment for relapsed large B-cell lymphoma, and she’s turning to GoFundMe for…

CC-486 extends OS in newly diagnosed acute myeloid leukemia

September 13, 2019
A randomized phase 3 trial designed to evaluate maintenance therapy with CC-486 for patients with newly diagnosed acute myeloid leukemia met its…

Ohio State cancer center appoints hematology division director

September 12, 2019
Yiping Yang, MD, PhD, has been appointed director of the division of hematology at The Ohio State University Comprehensive Cancer Center —…

Meeting News

IASLC: All physicians should screen patients with cancer for tobacco use

September 7, 2019
BARCELONA — The International Association for the Study of Lung Cancer, or IASLC, today issued a declaration at its World Conference on Lung…

Three scientists to receive Louisa Gross Horwitz Prize for research into key cancer pathway

September 6, 2019
Columbia University will award this year’s Louisa Gross Horwitz Prize to three scientists for their seminal contributions to understanding of…

Samuel Waxman Cancer Research Foundation awards $1.4 million in grants

September 5, 2019
The Samuel Waxman Cancer Research Foundation awarded $1.4 million worth of new grants to fund investigations into multiple scientific areas. The…

In the Journals

Childhood leukemia survivors may be at higher risk for infections

September 3, 2019
Childhood leukemia survivors demonstrated a higher long-term risk for infections after treatment completion than the general population, according to…

In the JournalsPerspective

Women underrepresented in leadership of oncologic randomized clinical trials

August 27, 2019
Oncologic randomized clinical trials published between 2003 and 2018 exhibited a low rate of female corresponding authorship in relation to the…